| Date | Form | Description | Docs | XBRL | Pages |
| 06/09/97 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
10 | |
| 03/14/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
26 | |
| 01/31/97 | 10-K405/A | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
2 | |
| 01/29/97 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
35 | |
| 11/27/96 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
11 | |
| 09/13/96 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 06/24/96 | DEF 14A | Definitive proxy statements |
|
14 | |
| 06/19/96 | 10-C | Change of number of shares outstanding or change of issuer name |
|
2 | |
| 06/18/96 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
1 | |
| 06/18/96 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...